Total Funding
86
86
Total FundingPost-IPO Equity raised
Growth Score
-9 pts
Heat Score
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
292
Humacyte develops products for vascular diseases and replacement of anatomical conduits.
- Laura Niklason: Founder
- Juliana L. Blum: Co-Founder and Executive AdvisorPast Role: Humacyte, Co-Founder & Executive Vice President, Strategic Business Operations
About the Company
Humacyte develops products for vascular disease and replacement of anatomical conduits. It offers human tissue-based products for regenerative medicine and vascular surgery applications; off-the-shelf extracellular matrix tissue products, which are formed in vitro from banked vascular smooth muscle cells and then decellularized to eliminate the
risk of rejection; and vascular grafts.
Women Founded
